B-CELL LYMPHOMA
![Epkinly: First And Only Fda-Approved Bispecific Antibody For Relapsed Or Refractory Diffuse Large B-Cell Lymphoma (Dlbcl)](https://pharmtales.com/wp-content/uploads/2023/06/Epkinly-First-And-Only-Fda-Approved-Bispecific-Antibody-For-Relapsed-Or-Refractory-Diffuse-Large-B-Cell-Lymphoma-Dlbcl-1.jpg)
Epkinly: FDA-Approved Bispecific Antibody for DLBCL
SG Tylor
On May 19, 2023, AbbVie announced that the U.S. Food and Drug Administration (FDA) granted approval to EPKINLYTM (epcoritamab-bysp) as ...
On May 19, 2023, AbbVie announced that the U.S. Food and Drug Administration (FDA) granted approval to EPKINLYTM (epcoritamab-bysp) as ...